申请人:ONTOGEN CORPORATION
公开号:EP0812829A1
公开(公告)日:1997-12-17
This invention relates to compounds of Formula 1 which are pharmacologically useful for the treatment of cancer through sensitization of multi-drug resistant cancer cells to chemotherapeutic agents.
wherein R1, R2, R3, and R4 are, for example, alkyl, aryl, etc., which are defined more specifically hereinafter.
本发明涉及式 1 化合物,其药理作用是通过使多重耐药癌细胞对化疗药物敏感来治疗癌症。
其中 R1、R2、R3 和 R4 例如为烷基、芳基等,下文将对其进行更具体的定义。